Carel B. Hoyng
Elite in Age-Related Macular Degeneration (ARMD)

Carel B. Hoyng

Nijmegen, GE, NL 

Elite in Age-Related Macular Degeneration (ARMD)
Nijmegen, GE, NL 
OverviewLocationsClinical Research

Overview

Carel Hoyng practices in Nijmegen, Netherlands. Hoyng is rated as an Elite expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Their top areas of expertise are Late-Onset Retinal Degeneration, Stargardt Macular Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Trabeculectomy.

Their clinical research consists of co-authoring 322 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 146 articles and participated in 1 clinical trial in the study of Age-Related Macular Degeneration (ARMD).

Locations

Nijmegen, GE, Netherlands
Other Locations
Leiden, ZH 2311EZ, Netherlands
Nijmegan, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

Development of Novel Clinical Endpoints for Interventional Clinical Trials With a Regulatory and Patient Access Intention in Patients With Intermediate Age-related Macular Degeneration (AMD)
Development of Novel Clinical Endpoints for Interventional Clinical Trials With a Regulatory and Patient Access Intention in Patients With Intermediate Age-related Macular Degeneration (AMD)
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2025
Intervention Type: Other
Natural History Study of CEP290-Related Retinal Degeneration
Natural History Study of CEP290-Related Retinal Degeneration
Enrollment Status: Completed
Publish Date: May 19, 2022
Double-masked, Randomized, Controlled, Multiple-dose Study to Evaluate Efficacy, Safety, Tolerability and Syst. Exposure of QR-110 in Leber's Congenital Amaurosis (LCA) Due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Double-masked, Randomized, Controlled, Multiple-dose Study to Evaluate Efficacy, Safety, Tolerability and Syst. Exposure of QR-110 in Leber's Congenital Amaurosis (LCA) Due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Enrollment Status: Active_not_recruiting
Publish Date: March 17, 2022
Intervention Type: Other, Drug
Study Phase: Phase 2/Phase 3
A Prospective Randomized Controlled Multicentre Trial Comparing Half-dose Photodynamic Therapy (PDT) With High-density Subthreshold Micropulse Laser Treatment in Patients With Chronic Central Serous Chorioretinopathy (CSC)
A Prospective Randomized Controlled Multicentre Trial Comparing Half-dose Photodynamic Therapy (PDT) With High-density Subthreshold Micropulse Laser Treatment in Patients With Chronic Central Serous Chorioretinopathy (CSC)
Enrollment Status: Completed
Publish Date: October 10, 2017
Intervention Type: Procedure
Study Phase: Phase 4
View 3 Less Clinical Trials

320 Total Publications

Associations Between Structural Phenotype and Polygenic Risk Scores in Intermediate Age-Related Macular Degeneration - A MACUSTAR Report.
Associations Between Structural Phenotype and Polygenic Risk Scores in Intermediate Age-Related Macular Degeneration - A MACUSTAR Report.
Journal: Translational vision science & technology
Published: September 26, 2025
View All 320 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hoyng's expertise for a condition
ConditionClose
  • Elite
  • Age-Related Macular Degeneration (ARMD)
    Hoyng is
    Elite
    . Learn about Age-Related Macular Degeneration (ARMD).
    See more Age-Related Macular Degeneration (ARMD) experts
  • Central Serous Chorioretinopathy
    Hoyng is
    Elite
    . Learn about Central Serous Chorioretinopathy.
    See more Central Serous Chorioretinopathy experts
  • Late-Onset Retinal Degeneration
    Hoyng is
    Elite
    . Learn about Late-Onset Retinal Degeneration.
    See more Late-Onset Retinal Degeneration experts
  • Retinitis Pigmentosa
    Hoyng is
    Elite
    . Learn about Retinitis Pigmentosa.
    See more Retinitis Pigmentosa experts
  • Retinopathy Pigmentary Mental Retardation
    Hoyng is
    Elite
    . Learn about Retinopathy Pigmentary Mental Retardation.
    See more Retinopathy Pigmentary Mental Retardation experts
  • Stargardt Macular Degeneration
    Hoyng is
    Elite
    . Learn about Stargardt Macular Degeneration.
    See more Stargardt Macular Degeneration experts
  • Distinguished
  • Choroideremia
    Hoyng is
    Distinguished
    . Learn about Choroideremia.
    See more Choroideremia experts
  • Geographic Atrophy
    Hoyng is
    Distinguished
    . Learn about Geographic Atrophy.
    See more Geographic Atrophy experts
  • Leber Congenital Amaurosis
    Hoyng is
    Distinguished
    . Learn about Leber Congenital Amaurosis.
    See more Leber Congenital Amaurosis experts
  • Usher Syndrome
    Hoyng is
    Distinguished
    . Learn about Usher Syndrome.
    See more Usher Syndrome experts
  • Usher Syndrome Type 2A
    Hoyng is
    Distinguished
    . Learn about Usher Syndrome Type 2A.
    See more Usher Syndrome Type 2A experts
  • Advanced
  • Adult-Onset Vitelliform Macular Dystrophy (AVMD)
    Hoyng is
    Advanced
    . Learn about Adult-Onset Vitelliform Macular Dystrophy (AVMD).
    See more Adult-Onset Vitelliform Macular Dystrophy (AVMD) experts
  • Bardet-Biedl Syndrome
    Hoyng is
    Advanced
    . Learn about Bardet-Biedl Syndrome.
    See more Bardet-Biedl Syndrome experts
  • Birdshot Chorioretinopathy
    Hoyng is
    Advanced
    . Learn about Birdshot Chorioretinopathy.
    See more Birdshot Chorioretinopathy experts
  • Blue Cone Monochromatism
    Hoyng is
    Advanced
    . Learn about Blue Cone Monochromatism.
    See more Blue Cone Monochromatism experts
  • Color Blindness
    Hoyng is
    Advanced
    . Learn about Color Blindness.
    See more Color Blindness experts
  • Cone Dystrophy
    Hoyng is
    Advanced
    . Learn about Cone Dystrophy.
    See more Cone Dystrophy experts
View All 11 Advanced Conditions
  • Experienced
  • Anemia
    Hoyng is
    Experienced
    . Learn about Anemia.
    See more Anemia experts
  • Atypical Hemolytic Uremic Syndrome (aHUS)
    Hoyng is
    Experienced
    . Learn about Atypical Hemolytic Uremic Syndrome (aHUS).
    See more Atypical Hemolytic Uremic Syndrome (aHUS) experts
  • Batten Disease
    Hoyng is
    Experienced
    . Learn about Batten Disease.
    See more Batten Disease experts
  • Cataract
    Hoyng is
    Experienced
    . Learn about Cataract.
    See more Cataract experts
  • Charles Bonnet Syndrome
    Hoyng is
    Experienced
    . Learn about Charles Bonnet Syndrome.
    See more Charles Bonnet Syndrome experts
  • Chromosome 6 Uniparental Disomy
    Hoyng is
    Experienced
    . Learn about Chromosome 6 Uniparental Disomy.
    See more Chromosome 6 Uniparental Disomy experts
View All 35 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved